Dr. Murugan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-672-7422
Summary
- Dr.Murugan is a board-certified anatomic pathologist specializing in genitourinary and soft tissue/bone tumors. Beyond his clinical diagnostic expertise, he is actively involved in resident/fellow education, and translational research. He has received multiple best teacher awards, authored over 95 peer-reviewed publications and has contributed to several R01 NIH grants. Dr.Murugan has delivered numerous scientific meeting presentations, authored book chapters and has lectured nationally and internationally. He is an associate editor of Diagnostic Pathology and editorial board member of the Annals of Diagnostic Pathology. Additionally, as a member of the College of American Pathologists' Cancer Committee, he has co-authored multiple genitourinary, soft tissue and bone cancer reporting protocols. Dr.Murugan also serves as Director of the University of Minnesota's Surgical Pathology Fellowship Program and Medical Director of the University’s Biorepository and Laboratory Services.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Genitourinary Pathology, 2013 - 2014
- University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2012 - 2013
- University of Oklahoma Health Sciences CenterResidency, Pathology-Anatomic and Clinical, 2009 - 2012
- Madras Medical CollegeClass of 2004
Certifications & Licensure
- MN State Medical License 2014 - 2025
- OK State Medical License 2011 - 2015
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- Spitz melanoma with MAP3K8::ABLIM1 rearrangement: a case report with review of the literature.Rayan Sibira, Anna Vu, Alessio Giubellino, Paari Murugan
Diagnostic Pathology. 2024-10-03 - Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases.Megan L Ludwig, David Moline, Alec Horrmann, Ella Boytim, Gabrianne Larson
NPJ Precision Oncology. 2024-09-30 - RAD51C and MYST3 Mutations in a Case of Desmoid-Type Fibromatosis With No Mutation in CTNNB1 or APC.Keith M Skubitz, Paari Murugan
Cureus. 2024-03-01
Journal Articles
- A Clinical Prediction Tool to Determine the Need for Concurrent Systematic Sampling at the Time of MRI‐Guided BiopsyBenjamin Spilseth, Badrinath R Konety, Maria A Ordonez, Christopher J Weight, Christopher A Warlick, Paari Murugan, BJU International
- Clonal Relatedness and Mutational Differences Between Upper Tract and Bladder Urothelial CarcinomaAditya Bagrodia, Paari Murugan, Clinical Cancer Research
- BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is a Potential Therapeutic Target: Hypothesis Tested in Race-Specific ModelsBadrinath R Konety, Paari Murugan, Clinical Cancer Research
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: